NEW YORK, Sept. 8, 2023 — LMG Life Sciences has named King & Spalding its 2023 Government Investigations Firm of the Year. The practice previously received this honor in 2020.
The firm also was honored with the Non-IP Impact Case of Year – United States award for its work in advising Boehringer Ingelheim obtain thousands of claims dismissed surrounding a federal multidistrict litigation matter against heartburn medicine Zantac. The King & Spalding team was led by Andy Bayman, Eva Canaan, Rob Friedman and Julia Zousmer.
King & Spalding’s Life Sciences and Healthcare industry team comprises more than 350 King & Spalding lawyers across the firm’s litigation, transactional and regulatory teams who devote all or a substantial portion of their practice to serving clients in every segment of the Life Sciences and Healthcare sectors.
Founded by former U.S. Attorney General Griffin Bell, the firm’s Special Matters and Government Investigations team exclusively focuses on white-collar criminal defense, civil and regulatory investigations, corporate internal investigations, and investigations before the U.S. Congress.
The LMG Life Sciences Awards honor firms, individuals and companies behind the most innovative and challenging life sciences work of the past year as identified from research it conducts through surveys and interviews with lawyers and clients, as well as public information.